» Authors » Adam Mamelak

Adam Mamelak

Explore the profile of Adam Mamelak including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 547
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Miller A, Shahrestani S, Michel M, Yu J, Mamelak A
Neurosurg Focus . 2024 Nov; 57(5):E8. PMID: 39486071
Objective: Laser interstitial thermal therapy (LITT) is a minimally invasive procedure used to ablate abnormal tissue in a targeted fashion. It is most commonly used to treat epileptic foci, brain...
2.
Mamelak A
Expert Rev Endocrinol Metab . 2022 Oct; 17(6):485-498. PMID: 36200144
Introduction: Treatment of prolactinomas with dopamine agonists has been the established first-line treatment option for many years, with surgery reserved for refractory cases or medication intolerance. This approach may not...
3.
Feinsinger A, Pouratian N, Ebadi H, Adolphs R, Andersen R, Beauchamp M, et al.
Neuron . 2022 Jan; 110(2):188-194. PMID: 35051364
Leveraging firsthand experience, BRAIN-funded investigators conducting intracranial human neuroscience research propose two fundamental ethical commitments: (1) maintaining the integrity of clinical care and (2) ensuring voluntariness. Principles, practices, and uncertainties...
4.
Ho K, Fleseriu M, Kaiser U, Salvatori R, Brue T, Lopes M, et al.
J Endocr Soc . 2021 Feb; 5(3):bvaa205. PMID: 33604494
The designates pituitary neoplasms as adenomas. A proposed nomenclature change to pituitary neuroendocrine tumors (PitNETs) has been met with concern by some stakeholder groups. The Pituitary Society coordinated the Pituitary...
5.
Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, et al.
Rev Endocr Metab Disord . 2020 Sep; 21(4):667-678. PMID: 32914330
The 13th Acromegaly Consensus Conference was held in November 2019 in Fort Lauderdale, Florida, and comprised acromegaly experts including endocrinologists and neurosurgeons who considered optimal approaches for multidisciplinary acromegaly management....
6.
Ben-Shlomo A, Deng N, Ding E, Yamamoto M, Mamelak A, Chesnokova V, et al.
J Clin Invest . 2020 Jul; 130(11):5738-5755. PMID: 32673291
Drivers of sporadic benign pituitary adenoma growth are largely unknown. Whole-exome sequencing of 159 prospectively resected pituitary adenomas showed that somatic copy number alteration (SCNA) rather than mutation is a...
7.
Zonis S, Breunig J, Mamelak A, Wawrowsky K, Bresee C, Ginzburg N, et al.
J Neuroinflammation . 2018 Sep; 15(1):260. PMID: 30201019
Background: Inflammation has been proposed to contribute to the decline in adult hippocampal neurogenesis. Proinflammatory cytokines activate transcription of chemokine growth-regulated oncogene α (Gro1) in human and murine hippocampal neuronal...
8.
Downes A, Pezeshkian P, Behnke E, Bordelon Y, Tagliati M, Mamelak A, et al.
Oper Neurosurg (Hagerstown) . 2018 Mar; 12(4):383-390. PMID: 29506283
Background: Cerebrovascular accident (CVA) is a potentially devastating complication of deep brain stimulation (DBS) surgery. Although there are substantial data reporting the incidence and cause of hemorrhagic CVA, reports of...
9.
Bonert V, Carmichael J, Wu Z, Mirocha J, Perez D, Clarke N, et al.
Pituitary . 2017 Dec; 21(1):65-75. PMID: 29218459
Purpose: Measuring IGF-1, a biomarker for GH activity, is critical to evaluating disordered hypothalamic-pituitary GH axis. Inconsistent IGF-1 measurements among different immunoassays are well documented. We switched from Immulite 2000...
10.
Patil R, Koronyo Y, Ljubimov A, Salumbides B, Mamelak A, Gangalum P, et al.
Bangk Med J . 2017 Nov; 10:83-97. PMID: 29142857
Professor Black and colleagues have been working to improve the quality and sensitivity of imaging in the early detection of conditions from brain tumors to Alzheimer's disease to enhance treatment...